Seattle Children's Ben Towne Center for Childhood Cancer Research is actively fighting pediatric leukemia by harvesting and reprogramming a child's own T cells and using the immune system to fight cancer.
Regulators have voted to approve America's first ever gene therapy for public use. An advisory panel of cancer experts at the Food and Drug Administration unanimously backed the one-time treatment at a meeting on Wednesday.
When I came to Seattle Children’s in 2010, my vision was for us to become a global epicenter for childhood cancer immunotherapy cures. I imagined that, someday, doctors from around the world would send us blood cells from children with cancer. We would insert instructions into T cells – a “warrior” type of immune cell – that tell them to find and kill cancer cells. Then we would send the “reprogrammed” cells back to the hospital, where the child would receive them as a simple infusion.